TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A November 3 MedPage Today neurology roundup highlighted a report on Edward Freytag, whose traumatic brain injury was described by The New York Times as making him a musical genius. It also summarized prospective data showing meaningful symptom improvement within three years for half of long COVID patients and a cohort study linking hospital delirium with later dementia and mild cognitive impairment.
MedPage Today published a neurology roundup on November 3, 2026, highlighting a New York Times account of Edward Freytag, whose traumatic brain injury was described as making him a musical genius, alongside research on long COVID improvement and delirium and later cognitive impairment. The research summaries point to potential changes in symptoms over time and an association between hospital delirium and subsequent dementia or mild cognitive impairment, but do not establish that delirium causes those conditions.
The roundup, written by MedPage Today Deputy Managing Editor Judy George, cited prospective findings from the RECOVER-Adult study, published in the Annals of Internal Medicine. The study reported that half of long COVID patients had meaningful symptom improvement within three years. The summary does not provide the number of participants, the definition of meaningful improvement, or details about how symptoms changed across that period.
A separate cohort study, reported in JAMA Neurology, found that delirium during hospitalization was strongly linked with dementia and mild cognitive impairment in later years. The roundup describes this as an association; it does not give the study’s size, the strength of the measured risk, or details needed to determine how other health factors may have contributed.
The roundup also cited the New York Times’ account of Edward Freytag, whose traumatic brain injury was reported to have led to exceptional musical ability. It did not provide details about the injury, the timing of changes in his musical skills, or clinical evidence explaining them. These items appeared alongside several other neurology developments, making the report a roundup rather than a single-study announcement.
Long COVID and Delirium Findings
The three highlighted stories concern different questions: how long COVID symptoms may change, whether delirium in hospital is associated with later cognitive problems, and how a brain injury may relate to musical ability. The long COVID result offers a time frame—meaningful improvement within three years—but does not mean all patients improve or predict an individual’s course.
The delirium finding matters to patients, families and clinicians because it connects an episode of acute confusion during hospitalization with later cognitive diagnoses. Since the reported result is observational, it cannot by itself show that delirium causes dementia or mild cognitive impairment. The Freytag account is an individual story, not evidence that brain injury generally produces exceptional musical skill.
Products Worth Considering
Oral-B iO Series 3 Rechargeable Electric Toothbrush for Adults, Black
Hyperice Hypervolt Go 3 Portable Percussion Massage Gun with Carry Case
Levoit Vital 100S-P Air Purifier with Washable Pre-Filter
As an affiliate, we earn on qualifying purchases.
Three Distinct Neurology Stories
MedPage Today presented the items as part of its coverage of neurology and neuroscience, not as a unified study or a claim that the findings share one cause. The long COVID result came from prospective data in RECOVER-Adult; the delirium result came from a separate cohort study. The report identifies their journals as the Annals of Internal Medicine and JAMA Neurology, respectively.
Other items in the roundup included a partial FDA clinical hold on Bright Minds Biosciences’ investigational seizure drug BMB-101 after toxicity was identified in mice, and FDA acceptance of uniQure’s application for its Huntington’s disease gene therapy candidate, with a decision expected the following May. Those company and regulatory updates are separate from the three developments described above.
“Half of long COVID patients had meaningful symptom improvement within 3 years.”
— MedPage Today, summarizing the RECOVER-Adult study
Limits of the Reported Findings
The roundup provides brief summaries rather than full study details. For the long COVID finding, it does not specify the participant count, how meaningful improvement was measured, or whether improvement was sustained. It also does not explain whether the result applies equally across different patient groups.
For delirium, the available summary does not give the cohort size, effect estimates, or possible confounding factors. The association does not show whether delirium contributes to later impairment, reflects underlying vulnerability, or both. The account of Freytag likewise supplies no clinical detail establishing how the injury and his musical abilities were related. The source material does not report a common explanation connecting the three stories.
Full Studies and Follow-Up
Readers seeking more detail will need the full RECOVER-Adult report and the JAMA Neurology cohort study, including their methods, participant characteristics and limitations. Further follow-up could clarify how long COVID symptoms change over time and how delirium relates to later cognitive outcomes, but the roundup does not specify a next publication or clinical milestone for either study.
The New York Times account provides the basis for the Freytag item; the MedPage Today summary does not identify further reporting or research planned on his case. For now, the confirmed development is the publication of the roundup and its summaries, not a new clinical guideline or a causal finding.
Key Questions
What did the long COVID study report?
The MedPage Today roundup said prospective RECOVER-Adult data, published in the Annals of Internal Medicine, found that half of long COVID patients had meaningful symptom improvement within three years. The summary does not provide further study details.
Does hospital delirium cause dementia?
The cited cohort study found a strong link between delirium during hospitalization and later dementia or mild cognitive impairment. An association alone does not establish cause and effect.
What is known about Edward Freytag?
The roundup relayed a New York Times account describing Freytag as a person whose traumatic brain injury made him a musical genius. The summary does not provide clinical details or establish a general effect of brain injury.
Were the three developments part of one study?
No. They are separate items in a neurology news roundup: an individual account, prospective long COVID data, and a cohort study about delirium and later cognition.
Source: medpagetoday.com
